LABORIZON acquired by BIOGROUP

EQT Infrastructure entered into exclusive negotiations with IK Investment Partners to acquire a majority stake in Colisée, marking a transition from private equity to infrastructure ownership. IK had previously acquired Colisée in 2017 from Eurazeo PME and the founding family. EQT is deploying capital from its fifth generation infrastructure fund — the largest infrastructure fund ever raised in Europe. The transaction is advised by Lazard on the seller side. EQT has stated its intention to support Colisée's continued growth into new geographic markets following closing.

VAM Investments acquired an 80% majority stake in Demenego from the founding De Menego family. This primary buyout transaction was designed to facilitate the transition of the company from a family-run business to a managerially-led retail platform. The founding family reinvested to retain a 20% minority stake, ensuring a smooth leadership handover. The strategic rationale for the deal centers on accelerating the growth of the store network and professionalizing the corporate structure.

Orpea acquired 50% of Brindley Healthcare, the fourth largest Irish nursing home operator, and simultaneously negotiated a call option enabling it to acquire the remaining 50% and reach full ownership by 2022. The transaction follows Orpea's acquisition of TLC Group earlier in January 2020 and confirms the group's strategic commitment to the Irish elderly care market, where it now becomes the second largest operator nationally. The two acquisitions — TLC and Brindley — are highly complementary geographically, with TLC concentrated in the Greater Dublin county and Brindley providing broader national coverage. Orpea's accelerated Irish development reflects its conviction in the structural growth opportunity presented by Ireland's significant nursing home capacity deficit, with the country targeting 10,000 additional places by 2031.

Asklepios and RHÖN founder Eugen Münch (together with Ingeborg Münch and HCM SE) agreed to pool their combined RHÖN shareholdings — representing nearly 50% of the capital — into a newly created joint venture. Under the terms of the agreement, the Münch family contributed approximately 7.6% of RHÖN shares directly into the joint venture and sold approximately 12.4% of RHÖN shares to Asklepios, which contributed these together with its existing RHÖN stake into the joint venture. Simultaneously, Asklepios announced a voluntary public tender offer for all remaining outstanding RHÖN shares at €18.00 per share in cash, subject solely to antitrust clearance and with no minimum acceptance threshold. Shares acquired through the tender offer will also be contributed into the joint venture, which is expected to hold at least approximately 49% of RHÖN's share capital post-closing. RHÖN will remain an independent company following the transaction. The strategic rationale centres on combining Asklepios's operational expertise and scale with RHÖN's Campus model and university hospital platform, unlocking network medicine, digital innovation, and new integrated care models across Germany.

Orpea Groupe acquired 100% of TLC Group from its founder marking the French nursing home giant's entry into the Irish market. The transaction follows Orpea's well-established pattern of entering new European markets through the acquisition of well-run, high-quality local platforms with strong occupancy rates and an established reputation, rather than through greenfield development. Ireland represented an attractive entry point for Orpea given the structural undersupply of nursing home capacity in the Greater Dublin region, strong demographic growth, and a regulatory and reimbursement framework broadly comparable to other Western European markets in which Orpea already operates.

Clariane (formerly operating as Korian) has finalized the definitive acquisition of Inicea, a premier psychiatric care provider, from Antin Infrastructure Partners. This landmark healthcare transaction positions the European care and hospitality giant among the top 3 private psychiatry operators in France. By merging Inicea's 19 specialized facilities with its own 11 existing clinics, the group scales its network to 30 specialized psychiatric and addiction clinics, effectively establishing a dedicated fourth business line focused on mental health within its French operations.

Vivalto Vie acquired 100% of Solimar, a Valencia-based nursing home operator, marking the group's first international expansion outside France. The transaction was executed simultaneously with the closing of the Amundi PEF-led LBO of Vivalto Vie and represents the first building block of the group's Spanish platform, which targets a pipeline of approximately 1,000 additional beds through a combination of further acquisitions and greenfield development projects.

Amundi PEF acquired a minority but leading stake in Vivalto Vie from Azulis Capital, which had been the group's largest shareholder since 2015 with approximately 35% of the capital. The sale process was mandated to Natixis Partners and Azulis Capital exited at a multiple exceeding 3x its initial investment. Société Générale Capital Partenaires entered the shareholder structure alongside Amundi PEF, while BNP Paribas Développement and Socadif retained small existing positions. Operational control of the group remains with Vivalto Partners. The transaction was financed through a unitranche facility provided by Ardian and a PIK instrument from CIC Private Debt and BNP Paribas PI, totalling €100 million, complemented by an €80 million capex line to support the group's development pipeline. Simultaneously with the LBO, Vivalto Vie completed the acquisition of Solimar in Spain, marking its first international expansion.

Vivalto Santé acquired Mathilde Médical Développement, adding four establishments — two clinics and two radiotherapy centres — to its existing Normandie footprint. The acquisition complements Vivalto Santé's existing presence in the region through the Clinique de l'Europe in Rouen and the Hôpital Pasteur in Evreux. The deal follows a series of acquisitions completed in 2019, including the Hôpital Privé du Confluent in Nantes, the Polyclinique de l'Europe in Saint-Nazaire, and the Polyclinique du Parc in Cholet, reflecting Vivalto Santé's ongoing buy-and-build strategy across the French private hospital market.

Ardian acquired a majority stake in Sante Cie from HLD and UI Gestion, who had controlled the company since 2015. Both HLD and UI Gestion reinvested significant capital alongside Ardian and the management team to support the next phase of growth. The transaction was designed to provide the group with the "firepower" to lead the consolidation of the fragmented French Home Healthcare market and to begin a pan-European expansion. The investment thesis focused on demographic tailwinds (aging population) and the structural shift in healthcare systems toward reducing hospital stays by favoring home-based medical support.